Bead-Based Notch Ligand Culture for Scalable T-Cell Generation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating large quantities of progenitor T cells from human hematopoietic stem/progenitor cells (HSPCs) are limited by the need for scale-up processing and lack of an effective, clinically applicable system, particularly in the context of hematopoietic stem cell transplantation where thymus dysfunction or atrophy leads to inadequate immune surveillance.
Innovation Solution
A cell-free, bead-based system using Notch ligands conjugated to suspension supports, such as microbeads, allows for the generation of T-lineage cells, including progenitor T cells, by culturing stem or progenitor cells in suspension, enabling scalable and automated production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional two-dimensional tissue culture platforms with immobilized Notch ligands are used, then T cell development can be induced, but the method is limited in scalability and cannot effectively generate large-scale cell numbers for clinical application
Solution Approach 1:
The patent transitions from two-dimensional plate-based culture to three-dimensional suspension culture using microbeads. This dimensional change enables scalable production by allowing cells to be cultured in suspension rather than adhering to flat surfaces, facilitating automated bioreactor systems and large-scale cell generation for clinical applications.
Solution Approach 2:
The patent introduces microbeads as an intermediary carrier for Notch ligands. Instead of directly immobilizing Notch ligands on culture plates, the ligands are conjugated to microbeads that can be suspended in culture medium. This intermediary approach maintains the essential Notch signaling function while enabling scalable suspension culture systems.
2Reliability
If mouse-derived OP9 cells expressing Notch ligands are used, then progenitor T cells can be generated, but the approach presents challenges for clinical translation and scale-up
Solution Approach 1:
The patent extracts the essential function of OP9 cells (providing Notch ligand signaling) and separates it from the complex stromal cell system. By isolating and conjugating only the Notch ligands to microbeads, the system removes the need for living OP9 cells while maintaining T cell development efficiency, thereby simplifying manufacturing and enabling clinical scalability.
Solution Approach 2:
The patent replaces expensive, complex OP9 stromal cells with inexpensive, non-living microbeads conjugated to Notch ligands. These microbeads can be produced in large quantities, are stable, and do not require cell culture maintenance, making the system economically viable and scalable for clinical manufacturing.
3Reliability
If thymus transplantation is performed to restore immune function, then T cell development can occur, but the procedure is complex and has limited availability
Solution Approach 1:
The patent creates an in vitro copy of the thymic microenvironment by conjugating Notch ligands (the key signaling molecules from thymic stromal cells) to microbeads. This artificial system replicates the essential T cell development signals without requiring actual thymus tissue transplantation, thereby simplifying the procedure while maintaining immune reconstitution effectiveness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach facilitates the generation of T-lineage cells, including progenitor T cells, in a clinically relevant manner, overcoming the limitations of previous methods by providing a scalable and efficient process for T cell reconstitution.
Implementation Method 1
A key signal that is delivered to the incoming lymphocyte progenitors by the thymus stromal cells is mediated by the Notch ligand Delta-like-4... Notch receptors expressed by lymphocyte progenitors require a mechanical pulling force that is induced by Delta-like-4 bearing cells in order for Notch receptor activation to be effectively induced
Data Source
AI summary
A method of generating cells of the T cell lineage is provided comprising (a) culturing a sample comprising stem cells or progenitor cells with a Notch ligand conjugated to a suspension support and (b) isolating cells of the T cell lineage. In one embodiment, the cells of the T-cell lineage are progenitor T cells or mature T cells. Compositions, kits and uses thereof are also provided.